HCA Holdings, Inc. (NYSE:HCA) Shares Sold by Rhumbline Advisers
Rhumbline Advisers decreased its stake in HCA Holdings, Inc. (NYSE:HCA) by 0.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 435,193 shares of the company’s stock after selling 3,633 shares during the period. Rhumbline Advisers’ holdings in HCA Holdings were worth $37,949,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Lee Financial Co bought a new position in HCA Holdings during the second quarter valued at $125,000. IFP Advisors Inc increased its position in HCA Holdings by 9.4% in the first quarter. IFP Advisors Inc now owns 1,605 shares of the company’s stock valued at $143,000 after buying an additional 138 shares during the period. Global X Management Co. LLC increased its position in HCA Holdings by 29.9% in the first quarter. Global X Management Co. LLC now owns 2,162 shares of the company’s stock valued at $192,000 after buying an additional 498 shares during the period. Peak Asset Management LLC bought a new position in HCA Holdings during the first quarter valued at $201,000. Finally, Ifrah Financial Services Inc. bought a new position in HCA Holdings during the first quarter valued at $210,000. Hedge funds and other institutional investors own 74.54% of the company’s stock.
Shares of HCA Holdings, Inc. (HCA) opened at 79.37 on Friday. HCA Holdings, Inc. has a one year low of $67.00 and a one year high of $91.03. The firm has a market cap of $28.67 billion, a P/E ratio of 10.64 and a beta of 0.67. The stock’s 50 day moving average is $83.56 and its 200-day moving average is $84.33.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing analysts’ consensus estimates of $1.80 by $0.05. The firm had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.66 EPS. Analysts anticipate that HCA Holdings, Inc. will post $7.17 EPS for the current fiscal year.
HCA has been the subject of several research analyst reports. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research report on Monday, April 17th. Zacks Investment Research upgraded shares of HCA Holdings from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research report on Thursday, July 13th. Argus assumed coverage on shares of HCA Holdings in a report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 price objective for the company. Morgan Stanley reiterated an “equal weight” rating and issued a $88.00 price objective (down previously from $90.00) on shares of HCA Holdings in a report on Wednesday, July 26th. Finally, Citigroup Inc. cut their price objective on shares of HCA Holdings from $89.00 to $87.00 and set a “neutral” rating for the company in a report on Wednesday, July 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the stock. HCA Holdings currently has an average rating of “Buy” and a consensus price target of $93.50.
In other news, insider Jonathan B. Perlin sold 71,063 shares of the business’s stock in a transaction that occurred on Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total value of $6,111,418.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Sandra L. Morgan sold 5,915 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $82.74, for a total transaction of $489,407.10. Following the completion of the transaction, the senior vice president now directly owns 2,420 shares of the company’s stock, valued at approximately $200,230.80. The disclosure for this sale can be found here. In the last three months, insiders sold 138,117 shares of company stock valued at $11,654,477. Company insiders own 2.90% of the company’s stock.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.